WOODLAND HILLS, Calif., Aug. 28, 2025 /PRNewswire/ — Dr. Robert G. Hale, a leading oral and maxillofacial surgeon, announced the introduction of the first FDA-approved device designed specifically to treat patients who are no longer candidates for traditional dental implants. The KLS Martin Preprosthetic provides a predictable, durable solution for individuals with edentulous ridge deformities or failed implant sites.
Until now, many patients with too little bone in the upper jaw (maxilla) or prior implant complications faced limited and often invasive alternatives such as extensive grafting, sinus lifts, or zygomatic implants. The KLS Martin Preprosthetic offers a groundbreaking option that can be placed in a minimally invasive procedure of approximately 90 minutes under procedural sedation, restoring function, comfort, and quality of life for patients previously told they had no viable path forward.
“Patients who have been told they are not candidates for implants finally have a solution,” said Dr. Robert G. Hale. “With the KLS Martin Preprosthetic, we can deliver a more predictable, efficient path to fixed teeth when traditional approaches have failed.”
As an early clinical researcher with the device, Dr. Hale is committed not only to patient care but also to elevation of the standard of care. He collaborates with KLS Martin and trains colleagues nationwide on this next-generation approach to implant dentistry.
The KLS Martin Preprosthetic has the potential to reshape implant dentistry by reducing complications, shortening treatment timelines, and offering an FDA-approved alternative when conventional implants are not possible.
For consultations and more information, visit www.RobertGHale.com.
About Dr. Robert G. Hale
Dr. Hale is an accomplished oral and maxillofacial surgeon recognized for pioneering work in advanced implant solutions. In addition to his clinical expertise, Dr. Hale brings decades of distinguished military service as a former Colonel in the United States Army Dental Corps. He has served in leadership roles at premier military medical centers, where he provided surgical care to service members and advanced research in maxillofacial reconstruction. Dr. Hale collaborates with leading medical device manufacturers to bring innovative, evidence-based technologies to patients, with a focus on predictable outcomes and patient comfort.
Media Contact:
Michael Stein
(818) 610-1092
pr@connectionmarketing.net
SOURCE Dr. Robert G. Hale
Telehealth Provider Offers FDA-Approved and Compounded Weight Loss Medications in All 50 States, Subject to…
Telehealth Platform Facilitates Compounded Semaglutide and Tirzepatide Access Through Licensed Provider Evaluation as FDA Shortage…
Analysis examines best peptides for boosting growth hormone as ReadyRx lists prescription sermorelin in injectable…
Discover the best fat burner for men in 2025. Explore Wolfson Brand’s effective fat-burning supplements…
Industry Analysis Examines How Cost, Safety, and Access Considerations Shape Semaglutide Choices as MEDVi Lists…
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex…